Yesterday I had my final presentation and critique for my recent project 'Re-Manufacturing'.
‘Future Manufacturing’ has acknowledged the mass production of aspirin. Its progression has led the research into an exploration of future usage of aspirin; ‘disrupting the physical consumption and materiality of the pharmaceutical industry’. Focussing on the natural elements involved in the production, the plant White Willow (Salix Alba), contains an extract known as Salicin, which has the same properties as the key compound Salicylic Acid present in aspirin.
The main area of research produced is exploring material design within pharmaceutical products, however, focussing on the natural production methodology, as opposed to the chemical production. The ideology of the project is to design alternative methods of physical consumption of aspirin by concentrating on Salicin’s herbal medicinal purposes. The willow bark is naturally sourced and produced in a smaller method in comparison to how it would be created on a mass-scale form. By altering the physical states of matter, the Salicin can be ingested in various ways dependant on the consumer’s particular choice; intentionally redesigning the way consumers interact with the material and vice versa.
Below is some of the final research and products that I presented.
Natural Alternatives Infographic
Daily Dosage Information
Final Product Range
Feedback to consider:
1) How would you push the project forward?
2) How do you gage the success of your medicines?
3) How would you take your medicine into the real world?
Designed by Jack Newbury